Loading…

Industry funding of patients' support groups: Objectives of patients, clinicians, and industry are similar

EDITOR-As the British umbrella organisation representing the interests of all people with skin diseases and their patients' groups, the Skin Care Campaign welcomed the balanced approach taken by Herxheimer in his article on the relationship between the pharmaceutical industry and patients'...

Full description

Saved in:
Bibliographic Details
Published in:BMJ 2003-08, Vol.327 (7410), p.343-344
Main Author: Lapsley, Peter M
Format: Article
Language:English
Subjects:
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-b491t-b3897f0567cb536db1cda3d1cd6ceb4adafdc46cd8f6640abe699f2984e6d49f3
cites
container_end_page 344
container_issue 7410
container_start_page 343
container_title BMJ
container_volume 327
creator Lapsley, Peter M
description EDITOR-As the British umbrella organisation representing the interests of all people with skin diseases and their patients' groups, the Skin Care Campaign welcomed the balanced approach taken by Herxheimer in his article on the relationship between the pharmaceutical industry and patients' organisations. 1 However, we contest the argument that industry will if nothing else influence policy if it directly or indirectly funds a large part of the budget.
doi_str_mv 10.1136/bmj.327.7410.343-c
format article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_1126748</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>73545818</sourcerecordid><originalsourceid>FETCH-LOGICAL-b491t-b3897f0567cb536db1cda3d1cd6ceb4adafdc46cd8f6640abe699f2984e6d49f3</originalsourceid><addsrcrecordid>eNqNkU1rFTEUhoNY7KXtH3AhQUE3zjWZfLsQpKgtFLrRdcjk45phJjMmM4X-e3O5V61CwU0STp7zcg4PAM8x2mJM-Ltu7LekFVtBa4VQ0tgnYIMplw2ThDwFG6SYaiQm8hRclNIjhFoipOLsGTjFrUKCIboB_XVya1nyPQxrcjHt4BTgbJbo01LewLLO85QXuMvTOpf38LbrvV3inS8PubfQDjFFG02qb5McjL9STfawxDEOJp-Dk2CG4i-O9xn49vnT18ur5ub2y_Xlx5umowovTUekEgExLmzHCHcdts4QV09ufUeNM8FZyq2TgXOKTOe5UqFVknruqArkDHw45M5rN3pn64TZDHrOcTT5Xk8m6r9_Uvyud9Odxrjlgsoa8PoYkKcfqy-LHmOxfhhM8tNatCCMMon34Mt_wH5ac6rL6RZRRCvHK_TqMQgLIThmrWor1R4om6dSsg-_58VI74XrKlxX4XovXFfh2tamFw83_dNy1FuB5gDsm_8j8Cck4bgW</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1777615292</pqid></control><display><type>article</type><title>Industry funding of patients' support groups: Objectives of patients, clinicians, and industry are similar</title><source>Applied Social Sciences Index &amp; Abstracts (ASSIA)</source><source>BMJ journals single titles</source><source>JSTOR Archival Journals and Primary Sources Collection</source><creator>Lapsley, Peter M</creator><creatorcontrib>Lapsley, Peter M</creatorcontrib><description>EDITOR-As the British umbrella organisation representing the interests of all people with skin diseases and their patients' groups, the Skin Care Campaign welcomed the balanced approach taken by Herxheimer in his article on the relationship between the pharmaceutical industry and patients' organisations. 1 However, we contest the argument that industry will if nothing else influence policy if it directly or indirectly funds a large part of the budget.</description><edition>International edition</edition><identifier>ISSN: 0959-8138</identifier><identifier>ISSN: 0959-8146</identifier><identifier>EISSN: 1468-5833</identifier><identifier>EISSN: 1756-1833</identifier><identifier>DOI: 10.1136/bmj.327.7410.343-c</identifier><identifier>PMID: 12907504</identifier><identifier>CODEN: BMJOAE</identifier><language>eng</language><publisher>England: BMJ Publishing Group LTD</publisher><subject>Bioethics ; Consumer Organizations - economics ; Drug Industry - economics ; Financing, Organized ; Funding ; Interprofessional Relations ; Letters ; Patients ; Pharmaceutical industry ; Skin ; Skin diseases ; Social support ; Support groups</subject><ispartof>BMJ, 2003-08, Vol.327 (7410), p.343-344</ispartof><rights>2003 BMJ Publishing Group Ltd.</rights><rights>Copyright: 2003 (c) 2003 BMJ Publishing Group Ltd.</rights><rights>Copyright National Library of Medicine - MEDLINE Abstracts Aug 9 2003</rights><rights>Copyright © 2003, BMJ Publishing Group Ltd. 2003</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-b491t-b3897f0567cb536db1cda3d1cd6ceb4adafdc46cd8f6640abe699f2984e6d49f3</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttp://bmj.com/content/327/7410/343.4.full.pdf$$EPDF$$P50$$Gbmj$$H</linktopdf><linktohtml>$$Uhttp://bmj.com/content/327/7410/343.4.full$$EHTML$$P50$$Gbmj$$H</linktohtml><link.rule.ids>112,113,230,314,780,784,885,3194,27924,27925,30999,77594,77595</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/12907504$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Lapsley, Peter M</creatorcontrib><title>Industry funding of patients' support groups: Objectives of patients, clinicians, and industry are similar</title><title>BMJ</title><addtitle>BMJ</addtitle><description>EDITOR-As the British umbrella organisation representing the interests of all people with skin diseases and their patients' groups, the Skin Care Campaign welcomed the balanced approach taken by Herxheimer in his article on the relationship between the pharmaceutical industry and patients' organisations. 1 However, we contest the argument that industry will if nothing else influence policy if it directly or indirectly funds a large part of the budget.</description><subject>Bioethics</subject><subject>Consumer Organizations - economics</subject><subject>Drug Industry - economics</subject><subject>Financing, Organized</subject><subject>Funding</subject><subject>Interprofessional Relations</subject><subject>Letters</subject><subject>Patients</subject><subject>Pharmaceutical industry</subject><subject>Skin</subject><subject>Skin diseases</subject><subject>Social support</subject><subject>Support groups</subject><issn>0959-8138</issn><issn>0959-8146</issn><issn>1468-5833</issn><issn>1756-1833</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2003</creationdate><recordtype>article</recordtype><sourceid>7QJ</sourceid><recordid>eNqNkU1rFTEUhoNY7KXtH3AhQUE3zjWZfLsQpKgtFLrRdcjk45phJjMmM4X-e3O5V61CwU0STp7zcg4PAM8x2mJM-Ltu7LekFVtBa4VQ0tgnYIMplw2ThDwFG6SYaiQm8hRclNIjhFoipOLsGTjFrUKCIboB_XVya1nyPQxrcjHt4BTgbJbo01LewLLO85QXuMvTOpf38LbrvV3inS8PubfQDjFFG02qb5McjL9STfawxDEOJp-Dk2CG4i-O9xn49vnT18ur5ub2y_Xlx5umowovTUekEgExLmzHCHcdts4QV09ufUeNM8FZyq2TgXOKTOe5UqFVknruqArkDHw45M5rN3pn64TZDHrOcTT5Xk8m6r9_Uvyud9Odxrjlgsoa8PoYkKcfqy-LHmOxfhhM8tNatCCMMon34Mt_wH5ac6rL6RZRRCvHK_TqMQgLIThmrWor1R4om6dSsg-_58VI74XrKlxX4XovXFfh2tamFw83_dNy1FuB5gDsm_8j8Cck4bgW</recordid><startdate>20030809</startdate><enddate>20030809</enddate><creator>Lapsley, Peter M</creator><general>BMJ Publishing Group LTD</general><general>BMJ Publishing Group</general><general>BMJ Publishing Group Ltd</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88I</scope><scope>8AF</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>ASE</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>BTHHO</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FPQ</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>HCIFZ</scope><scope>K6X</scope><scope>K9.</scope><scope>LK8</scope><scope>M2O</scope><scope>M2P</scope><scope>M7P</scope><scope>MBDVC</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope><scope>7QJ</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20030809</creationdate><title>Industry funding of patients' support groups: Objectives of patients, clinicians, and industry are similar</title><author>Lapsley, Peter M</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-b491t-b3897f0567cb536db1cda3d1cd6ceb4adafdc46cd8f6640abe699f2984e6d49f3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2003</creationdate><topic>Bioethics</topic><topic>Consumer Organizations - economics</topic><topic>Drug Industry - economics</topic><topic>Financing, Organized</topic><topic>Funding</topic><topic>Interprofessional Relations</topic><topic>Letters</topic><topic>Patients</topic><topic>Pharmaceutical industry</topic><topic>Skin</topic><topic>Skin diseases</topic><topic>Social support</topic><topic>Support groups</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Lapsley, Peter M</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Science Database (Alumni Edition)</collection><collection>STEM Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>British Nursing Index</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>BMJ Journals</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central</collection><collection>British Nursing Index (BNI) (1985 to Present)</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>SciTech Premium Collection (Proquest) (PQ_SDU_P3)</collection><collection>British Nursing Index</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>ProQuest Biological Science Collection</collection><collection>ProQuest research library</collection><collection>ProQuest Science Journals</collection><collection>Biological Science Database</collection><collection>Research Library (Corporate)</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><collection>Applied Social Sciences Index &amp; Abstracts (ASSIA)</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>BMJ</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Lapsley, Peter M</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Industry funding of patients' support groups: Objectives of patients, clinicians, and industry are similar</atitle><jtitle>BMJ</jtitle><addtitle>BMJ</addtitle><date>2003-08-09</date><risdate>2003</risdate><volume>327</volume><issue>7410</issue><spage>343</spage><epage>344</epage><pages>343-344</pages><issn>0959-8138</issn><issn>0959-8146</issn><eissn>1468-5833</eissn><eissn>1756-1833</eissn><coden>BMJOAE</coden><abstract>EDITOR-As the British umbrella organisation representing the interests of all people with skin diseases and their patients' groups, the Skin Care Campaign welcomed the balanced approach taken by Herxheimer in his article on the relationship between the pharmaceutical industry and patients' organisations. 1 However, we contest the argument that industry will if nothing else influence policy if it directly or indirectly funds a large part of the budget.</abstract><cop>England</cop><pub>BMJ Publishing Group LTD</pub><pmid>12907504</pmid><doi>10.1136/bmj.327.7410.343-c</doi><tpages>2</tpages><edition>International edition</edition><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0959-8138
ispartof BMJ, 2003-08, Vol.327 (7410), p.343-344
issn 0959-8138
0959-8146
1468-5833
1756-1833
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_1126748
source Applied Social Sciences Index & Abstracts (ASSIA); BMJ journals single titles; JSTOR Archival Journals and Primary Sources Collection
subjects Bioethics
Consumer Organizations - economics
Drug Industry - economics
Financing, Organized
Funding
Interprofessional Relations
Letters
Patients
Pharmaceutical industry
Skin
Skin diseases
Social support
Support groups
title Industry funding of patients' support groups: Objectives of patients, clinicians, and industry are similar
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-04T21%3A57%3A38IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Industry%20funding%20of%20patients'%20support%20groups:%20Objectives%20of%20patients,%20clinicians,%20and%20industry%20are%20similar&rft.jtitle=BMJ&rft.au=Lapsley,%20Peter%20M&rft.date=2003-08-09&rft.volume=327&rft.issue=7410&rft.spage=343&rft.epage=344&rft.pages=343-344&rft.issn=0959-8138&rft.eissn=1468-5833&rft.coden=BMJOAE&rft_id=info:doi/10.1136/bmj.327.7410.343-c&rft_dat=%3Cproquest_pubme%3E73545818%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-b491t-b3897f0567cb536db1cda3d1cd6ceb4adafdc46cd8f6640abe699f2984e6d49f3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1777615292&rft_id=info:pmid/12907504&rfr_iscdi=true